S. Zonato

520 total citations
21 papers, 375 citations indexed

About

S. Zonato is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, S. Zonato has authored 21 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 5 papers in Surgery. Recurrent topics in S. Zonato's work include Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). S. Zonato is often cited by papers focused on Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). S. Zonato collaborates with scholars based in Italy, Russia and United States. S. Zonato's co-authors include Daris Ferrari, Andrea Luciani, Tiziana Ascione, S. Caldiera, Carla Codecà, Irene Floriani, Paolo Foa, Giuseppe Di Maria, P. Foa and Elena Di Gennaro and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

S. Zonato

20 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Zonato Italy 11 181 128 116 90 57 21 375
Mohamed Ramdani France 6 123 0.7× 78 0.6× 84 0.7× 101 1.1× 49 0.9× 10 299
S. Luce Belgium 4 146 0.8× 88 0.7× 156 1.3× 113 1.3× 37 0.6× 10 320
Yat Ming Lau China 7 142 0.8× 89 0.7× 118 1.0× 70 0.8× 49 0.9× 13 350
Rawad Elias United States 10 389 2.1× 159 1.2× 63 0.5× 54 0.6× 48 0.8× 28 535
Vikas Talreja India 9 121 0.7× 151 1.2× 50 0.4× 30 0.3× 59 1.0× 29 279
Willemieke P.M. Dijksterhuis Netherlands 12 171 0.9× 215 1.7× 52 0.4× 116 1.3× 199 3.5× 30 463
Alexander S. Qian United States 10 68 0.4× 52 0.4× 62 0.5× 46 0.5× 94 1.6× 44 329
En Cheng United States 11 222 1.2× 71 0.6× 18 0.2× 111 1.2× 37 0.6× 30 420
Almuth Klippstein Germany 5 140 0.8× 43 0.3× 134 1.2× 90 1.0× 26 0.5× 5 311
Rajiv Panikkar United States 7 97 0.5× 43 0.3× 47 0.4× 100 1.1× 21 0.4× 14 258

Countries citing papers authored by S. Zonato

Since Specialization
Citations

This map shows the geographic impact of S. Zonato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Zonato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Zonato more than expected).

Fields of papers citing papers by S. Zonato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Zonato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Zonato. The network helps show where S. Zonato may publish in the future.

Co-authorship network of co-authors of S. Zonato

This figure shows the co-authorship network connecting the top 25 collaborators of S. Zonato. A scholar is included among the top collaborators of S. Zonato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Zonato. S. Zonato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luciani, Andrea, et al.. (2023). Recent advances in small cell lung cancer: the future is now?. Minerva Endocrinology. 47(4). 2 indexed citations
2.
Luciani, Andrea, et al.. (2020). Recent advances in small cell lung cancer: the future is now?. Minerva Endocrinology. 47(4). 460–474. 3 indexed citations
3.
Marra, Antonio, C. Codecà, Maria Di Blasi, et al.. (2019). Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study. Acta Otorhinolaryngologica Italica. 39(2). 84–91. 25 indexed citations
4.
Luciani, Andrea, Luca Toschi, S. Fava, et al.. (2018). Immunotherapy in elderly patients (≥ 75 yrs) with advanced non-small cell lung cancer (NSCLC): A multicenter Italian experience. Annals of Oncology. 29. viii533–viii533. 6 indexed citations
5.
Ferrari, Daris, Carla Codecà, Maria Di Blasi, et al.. (2016). Radiotherapy and cetuximab for elderly patients affected by loco-regionally advanced head and neck cancer. Annals of Oncology. 27. iv88–iv88.
6.
Ferrari, Daris, Carla Codecà, Giulia Viale, et al.. (2015). Anti-epidermal growth factor receptor skin toxicity. Anti-Cancer Drugs. 27(2). 144–146. 3 indexed citations
7.
Luciani, Andrea, Lorenzo Dottorini, Nicolò Matteo Luca Battisti, et al.. (2012). Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA). Annals of Oncology. 24(2). 469–474. 20 indexed citations
8.
Luciani, Andrea, Tiziana Ascione, Carla Codecà, et al.. (2010). Detecting Disabilities in Older Patients With Cancer: Comparison Between Comprehensive Geriatric Assessment and Vulnerable Elders Survey-13. Journal of Clinical Oncology. 28(12). 2046–2050. 146 indexed citations
9.
Ferrari, Daris, Carla Codecà, Giuseppe Di Maria, et al.. (2009). A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer. Anti-Cancer Drugs. 20(3). 185–190. 21 indexed citations
10.
Luciani, Andrea, Tiziana Ascione, Elena Di Gennaro, et al.. (2009). Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer. Lung Cancer. 66(1). 94–96. 32 indexed citations
11.
Luciani, Alain, Tiziana Ascione, Giuseppe Colloca, et al.. (2009). P96 The impact of chemotherapy on body composition and functional status in elderly cancer patients. Critical Reviews in Oncology/Hematology. 72(1). S52–S53. 1 indexed citations
12.
Luciani, Andrea, Tiziana Ascione, S. Caldiera, et al.. (2008). Clinical analysis of multiple primary malignancies in the elderly. Medical Oncology. 26(1). 27–31. 23 indexed citations
13.
Borghi, Elisa, Lidia Gazzola, Giulia Marchetti, et al.. (2008). Rhodococcus equi infection in a patient with spinocellular carcinoma of unknown origin. Journal of Medical Microbiology. 57(11). 1431–1433. 7 indexed citations
14.
Luciani, Andrea, Tiziana Ascione, S. Caldiera, et al.. (2006). Do Elderly Cancer Patients Achieve an Adequate Dose Intensity in Common Clinical Practice?. Oncology. 71(5-6). 382–387. 4 indexed citations
16.
Lissoni, Paolo, Mario Mandalà, Luisa Giani, et al.. (2000). Efficacy of bromocriptine in the treatment of metastatic breast cancer- and prostate cancer-related hyperprolactinemia.. PubMed. 21(5). 405–408. 10 indexed citations
17.
Cascinu, Stefano, L. Frontini, G. Comella, et al.. (1999). Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). British Journal of Cancer. 79(3-4). 491–494. 4 indexed citations
18.
Martignoni, Giancarlo, et al.. (1998). Increasing Doses of 5-Fluorouracil and High-Dose Folinic ACID in the Treatment of Metastatic Colorectal Cancer. Tumori Journal. 84(6). 662–665. 11 indexed citations
20.
Piazza, E., V. Filipazzi, L. Isa, et al.. (1994). Cisplatin-vinorelbine (DDP+VBN) association chemotherapy in the treatment of locally advanced N.S.C.L.C.. Lung Cancer. 11. 128–128. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026